Chemical activators of ZNF385 can influence its function through a variety of biochemical pathways. Zinc acetate provides zinc ions that are necessary for the structural integrity of the zinc finger motifs of ZNF385, ensuring its ability to bind DNA and carry out its regulatory functions. Lithium chloride, on the other hand, indirectly contributes to the activation of ZNF385 by inhibiting GSK-3, a kinase that can regulate a wide array of proteins through phosphorylation. This inhibition can lead to the activation of various transcription factors, including ZNF385. Forskolin increases intracellular cAMP levels, which activate PKA. The activated PKA is then capable of phosphorylating target proteins, potentially leading to the phosphorylation and subsequent activation of ZNF385. Ionomycin elevates intracellular calcium levels, which activates calcium-dependent kinases, and these kinases can directly phosphorylate ZNF385, resulting in its activation.
Furthermore, Phorbol 12-myristate 13-acetate (PMA) activates PKC, which is known for phosphorylating a plethora of proteins, including possibly ZNF385, leading to its activation. Similarly, sodium orthovanadate acts as a phosphatase inhibitor, which can result in ZNF385 remaining phosphorylated and thus in an active state. Epidermal Growth Factor (EGF) stimulates its receptor, setting off a cascade of phosphorylation events that can culminate in the activation of ZNF385. Hydrogen peroxide, by generating oxidative stress, can activate signaling pathways that lead to the phosphorylation and activation of ZNF385. Sodium nitroprusside releases nitric oxide, triggering guanylate cyclase and increasing cGMP levels, which can activate kinases that phosphorylate ZNF385. Okadaic acid and Calyculin A, both phosphatase inhibitors, prevent dephosphorylation, which often results in the activation of phosphorylated proteins, including ZNF385. Lastly, dibutyryl cyclic AMP, a cAMP analog, activates PKA, which can then phosphorylate and activate ZNF385. Each of these chemicals, through their respective pathways, ensures the proper phosphorylation and functioning of ZNF385.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions provided by zinc acetate can activate ZNF385 by binding to its zinc finger motifs, which are critical for the structural integrity of the protein and its DNA-binding activity, leading to the functional activation of ZNF385. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can activate ZNF385 through its role in the glycogen synthase kinase 3 (GSK-3) pathway by inhibiting GSK-3, thus promoting activities that lead to activation of transcription factors including ZNF385. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, increases intracellular calcium levels, which activates calcium-dependent kinases that can phosphorylate ZNF385, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins, potentially including ZNF385, resulting in its activation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate acts as a phosphatase inhibitor, maintaining proteins in a phosphorylated state. This inhibition can lead to the activation of ZNF385, as it would remain phosphorylated and active. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As an oxidative agent, hydrogen peroxide can activate signaling pathways that respond to oxidative stress, which may include the activation of kinases that phosphorylate and activate ZNF385. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroprusside releases nitric oxide, which activates guanylate cyclase, increasing cGMP levels. This increase can lead to the activation of protein kinases that could phosphorylate and activate ZNF385. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of various proteins. This increase in phosphorylation may lead to the activation of ZNF385. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
Dibutyryl cyclic AMP, a cAMP analog, activates protein kinase A (PKA), which can phosphorylate and thereby activate ZNF385. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases, particularly PP1 and PP2A, similar to okadaic acid. This inhibition can lead to the hyperphosphorylation of proteins, potentially leading to the activation of ZNF385 through phosphorylation. | ||||||